Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Journal Article
Koiou, E., Dinas K., Tziomalos K., Toulis K., Kandaraki E. A., Kalaitzakis E., et al. (2011).  The phenotypes of polycystic ovary syndrome defined by the 1990 diagnostic criteria are associated with higher serum vaspin levels than the phenotypes introduced by the 2003 criteria.. Obes Facts. 4(2), 145-50.
Katsikis, I., Karkanaki A., Misichronis G., Delkos D., Kandaraki E. A., & Panidis D. (2011).  Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.. Eur J Obstet Gynecol Reprod Biol. 156(2), 181-5.
Papadimas, G. Konstantin, Kekou K., Papadopoulos C., Kararizou E., Kanavakis E., & Manta P. (2015).  Phenotypic variability and molecular genetics in proximal myotonic myopathy.. Muscle Nerve. 51(5), 686-91.
Hilgert, N., Huentelman M. J., Thorburn A. Q., Fransen E., Dieltjens N., Mueller-Malesinska M., et al. (2009).  Phenotypic variability of patients homozygous for the GJB2 mutation 35delG cannot be explained by the influence of one major modifier gene.. Eur J Hum Genet. 17(4), 517-24.
Abouzeid, H., Balmer A., Moulin A. P., Mataftsi A., Zografos L., & Munier F. L. (2012).  Phenotypic variability of retinocytomas: preregression and postregression growth patterns.. Br J Ophthalmol. 96(6), 884-9.
Boutou, A. K., Pitsiou G. G., Siakka P., Dimitroulas T., Paspala A., Sourla E., et al. (2016).  Phenotyping Exercise Limitation in Systemic Sclerosis: The Use of Cardiopulmonary Exercise Testing.. Respiration. 91(2), 115-23.
Karagiannis, A., Mikhailidis D. P., Athyros V. G., & Harsoulis F. (2007).  Pheochromocytoma: an update on genetics and management.. Endocr Relat Cancer. 14(4), 935-56.
Chatzizisis, Y. S., Ziakas A., Feloukidis C., Paramythiotis D., Hadjimiltiades S., Iliadis A., et al. (2014).  Pheochromocytoma crisis presenting with cardiogenic shock.. Herz. 39(1), 156-60.
Youssef, B., Pavlou G., & Tsiridis E. (2014).  Philadelphia 2013: international consensus meeting on periprosthetic joint infection.. Hip Int. 24(1), 3-4.
Papa, A., Kontana A., & Tsergouli K. (2015).  Phlebovirus infections in Greece.. J Med Virol. 87(7), 1072-6.
Hatzimouratidis, K. (2009).  Phosphodiesterase type 5 inhibitors: a viable treatment option for lower urinary tract symptoms?. Expert Opin Investig Drugs. 18(3), 245-54.
Hatzimouratidis, K., Burnett A. L., Hatzichristou D., McCullough A. R., Montorsi F., & Mulhall J. P. (2009).  Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application.. Eur Urol. 55(2), 334-47.
Hatzimouratidis, K., & Hatzichristou D. G. (2009).  Phosphodiesterase type 5 inhibitors: unmet needs.. Curr Pharm Des. 15(30), 3476-85.
Ioannides, D., Lazaridou E., Apalla Z., & Devliotou-Panagiotidou D. (2009).  Phosphodiesterase-5 inhibitors and rosacea: report of 10 cases.. Br J Dermatol. 160(3), 719-20.
Pafili, Z., Maridaki M., Giannaki C. D., Karatzaferi C., Liakopoulos V., Eleftheriadis T., et al. (2019).  Phosphorus nutritional knowledge among dialysis health care providers and patients: A multicenter observational study.. Clin Nutr ESPEN. 31, 33-37.
Galliou, P. Angeliki, Verrou K-M., & Koliakos G. (2019).  Phosphorylation mapping of laminin α1-chain: Kinases in association with active sites.. Comput Biol Chem. 80, 480-497.
Verrou, K-M., Galliou P. Angeliki, Papaioannou M., & Koliakos G. (2019).  Phosphorylation mapping of Laminin β1-chain: Kinases in association with active sites.. J Biosci. 44(2), 
Trakatelli, M., Charalampidis S., Novakovic L. B., Patsatsi A., Kalabalikis D., & Sotiriadis D. (2009).  Photodermatoses with onset in the elderly.. Br J Dermatol. 161 Suppl 3, 69-77.
Sotiriou, E., Koussidou-Eremonti T., Chaidemenos G., APALLA Z., & Ioannides D. (2010).  Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial.. Acta Derm Venereol. 90(2), 216-7.
Bakirtzi, K., Papadimitriou I., Vakirlis E., Lallas A., & Sotiriou E. (2023).  Photodynamic Therapy for Field Cancerization in the Skin: Where Do We Stand?. Dermatol Pract Concept. 13(4), 
Sotiriou, E., Apalla Z., Vrani F., Lallas A., Chovarda E., & Ioannides D. (2015).  Photodynamic therapy vs. imiquimod 5% cream as skin cancer preventive strategies in patients with field changes: a randomized intraindividual comparison study.. J Eur Acad Dermatol Venereol. 29(2), 325-329.
Sotiriou, E., Apalla Z., Chovarda E., Panagiotidou D., & Ioannides D. (2010).  Photodynamic therapy with 5-aminolevulinic acid in actinic cheilitis: an 18-month clinical and histological follow-up.. J Eur Acad Dermatol Venereol. 24(8), 916-20.
Pathakoti, K., Morrow S., Han C., Pelaez M., He X., Dionysiou D. D., et al. (2013).  Photoinactivation of Escherichia coli by sulfur-doped and nitrogen-fluorine-codoped TiO2 nanoparticles under solar simulated light and visible light irradiation.. Environ Sci Technol. 47(17), 9988-96.
Specchio, F., Argenziano G., Zalaudek I., Guardoli D., Longo C., Moscarella E., et al. (2014).  Photoletter to the editor: Collision tumor of melanoma and atypical fibroxanthoma of the scalp.. J Dermatol Case Rep. 8(3), 84-5.
Lallas, A., Apalla Z., Karteridou A., & Lefaki I. (2013).  Photoletter to the editor: Dermoscopy for discriminating between pityriasis rubra pilaris and psoriasis.. J Dermatol Case Rep. 7(1), 20-2.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.